1er Symposium canadien sur la COVID LONGUE
November 17, 2026
Speakers:

Prof. Dr. med. Carmen Scheibenbogen
-
Department of Immunodeficiencies and Post-Infectious Diseases, Institute of Medical Immunology | Charité
Time: 1:00 PM- 1:40 PM ET
Session Overview: This presentation will give an overview of the National Clinical Trial Network (NKSG) and its translational approach to developing targeted therapies for ME/CFS and other post-acute infection syndromes. The presentation will focus on antibody-targeting therapies, ranging from immunoadsorption to B-cell- and plasma-cell-targeted therapies
Professor Deborah Lupton, BA, LittB, MPH, PhD, FASSA, FRSN, FAHMS
-
Honorary Doctor of Social Science (Copenhagen)
-
Honorary Doctor of Health in the Digital Society (Skövde)
-
Centre for Social Research in Health and Social Policy Centre
-
University of New South Wales (UNSW) Sydney, Australia
Time: 6:00 PM- 6:40 PM ET
Session Overview: This presentation will discuss insights from my edited book 'Long COVID and Society: International Perspectives'

Note: Due to the time zones of our international speakers, we will host two separate webinars on the same day.
Moderator:
Susan Law, PhD
-
Knowledge Mobilization Lead, Long COVID Web
-
Associate Professor, Institute of Health Policy, Management and Evaluation
Attendees will have an opportunity to ask questions of the speakers following their presentations.
